Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FATE

Fate Therapeutics Inc

May 08 • 04:00PM ET

2.39

-0.04 -1.65 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NKTX ALLO LYEL SANA PGEN

| Held by: IWM VTI IWN VXF SCHA PRFZ IWC VTWO VHT DFAT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.15	Insider Own	5.26%	Shs Outstand	115.36M	Perf Week	56.21%
Market Cap	277.87M	Forward P/E	-	EPS next Y	-1.07	Insider Trans	-0.26%	Shs Float	110.14M	Perf Month	88.19%
Enterprise Value	152.06M	PEG	-	EPS next Q	-0.28	Inst Own	71.61%	Short Float	9.33%	Perf Quarter	109.65%
Income	-136.31M	P/S	41.78	EPS this Y	1.42%	Inst Trans	-0.04%	Short Ratio	5.45	Perf Half Y	119.27%
Sales	6.65M	P/B	1.33	EPS next Y	5.79%	ROA	-35.89%	Short Interest	10.28M	Perf YTD	143.23%
Book/sh	1.80	P/C	1.36	EPS next 5Y	2.62%	ROE	-51.84%	52W High	2.46 -3.04%	Perf Year	132.04%
Cash/sh	1.75	P/FCF	-	EPS past 3/5Y	26.67% 11.42%	ROIC	-48.60%	52W Low	0.91 162.64%	Perf 3Y	-56.15%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-58.98% -26.71%	Gross Margin	-94.12%	Volatility	15.45% 9.61%	Perf 5Y	-96.88%
Dividend TTM	-	EV/Sales	22.87	EPS Y/Y TTM	30.42%	Oper. Margin	-2222.45%	ATR (14)	0.17	Perf 10Y	39.77%
Dividend Ex-Date	-	Quick Ratio	5.79	Sales Y/Y TTM	-51.24%	Profit Margin	-2051.08%	RSI (14)	80.48	Recom	1.91
Dividend Gr. 3/5Y	- -	Current Ratio	5.79	EPS Q/Q	38.69%	SMA20	52.42%	Beta	2.19	Target Price	5.17
Payout	-	Debt/Eq	0.38	Sales Q/Q	-26.40%	SMA50	74.94%	Rel Volume	1.51	Prev Close	2.43
Employees	161	LT Debt/Eq	0.35	Earnings	Feb 26 BMO	SMA200	97.83%	Avg Volume	1.88M	Price	2.39
IPO	Oct 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.15% 2.42%	Trades		Volume	2,845,041	Change	-1.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)